Thus, for severe and progressive secondary hyperparathyroidism (SHPT) in CKD G5D, calcitriol or vitamin D analogues should be considered, with an initially low dose, independent of the initial PTH concentration, and then titrated based on the PTH response, and hypercalcaemia should be avoided [6]. Here, PTH is linked to secondary hyperparathyroidism.